» Articles » PMID: 10699704

Hydration of Lipid Films with an Aqueous Solution of Quil A: a Simple Method for the Preparation of Immune-stimulating Complexes

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2000 Mar 4
PMID 10699704
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Immune-stimulating complexes (ISCOMs) are stable colloidal complexes of the adjuvant Quil A, cholesterol and phospholipid, which are effective carriers for subunit vaccines. The techniques currently available for the preparation of ISCOMs from the constituent components are rather complex and are based on either centrifugation or dialysis. This note reports a new simple procedure for the preparation of ISCOM matrices based on hydration of a cholesterol/phospholipid film with an aqueous solution of Quil A. It is demonstrated that ISCOM matrices do not form in the absence of phospholipid when prepared by this method. Further, the ratio by weight of phospholipid to either cholesterol or Quil A must be greater than that required for preparation by either dialysis or centrifugation. Photon correlation spectroscopy, negative stain transmission electron microscopy and centrifugation through a sucrose gradient demonstrate that ISCOM matrices can be prepared from cholesterol/lipid films by hydration with an aqueous solution of Quil A when the ratio of phospholipid:cholesterol:Quil A by weight is 6:1:4, respectively. Lower ratios of phospholipid:cholesterol reduce the efficiency of ISCOM formation while higher ratios produce systems containing a mixture of ISCOMs together with liposomes.

Citing Articles

ISCOM-type matrix from beta-escin and glycyrrhizin saponins.

Petkov V, Tsibranska S, Manoylov I, Kechidzhieva L, Ilieva K, Bradyanova S Heliyon. 2025; 11(2):e41935.

PMID: 39897917 PMC: 11786834. DOI: 10.1016/j.heliyon.2025.e41935.


Development of Glycyrrhizinic Acid-Based Lipid Nanoparticle (LNP-GA) as An Adjuvant That Improves the Immune Response to Porcine Epidemic Diarrhea Virus Spike Recombinant Protein.

Garcia-Cambron J, Cerriteno-Sanchez J, Lara-Romero R, Quintanar-Guerrero D, Blancas-Flores G, Sanchez-Gaytan B Viruses. 2024; 16(3).

PMID: 38543796 PMC: 10974312. DOI: 10.3390/v16030431.


Mucosal and systemic immunization against tuberculosis by ISCOMATRIX nano adjuvant co-administered with alginate coated chitosan nanoparticles.

Najafi A, Ghazvini K, Sankian M, Gholami L, Zare S, Yousefi Arvand A Iran J Basic Med Sci. 2023; 26(10):1162-1167.

PMID: 37736514 PMC: 10510487. DOI: 10.22038/IJBMS.2023.67564.14806.


A vaccine targeting basic fibroblast growth factor elicits a protective immune response against murine melanoma.

Zhang X, Li N, Guo C, Li Y, Luo L, Liu Y Cancer Biol Ther. 2018; 19(6):518-524.

PMID: 29405828 PMC: 5927703. DOI: 10.1080/15384047.2018.1435223.


Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems.

Sanina N, Chopenko N, Mazeika A, Kostetsky E Biomed Res Int. 2017; 2017:4389525.

PMID: 28808657 PMC: 5541816. DOI: 10.1155/2017/4389525.